Although CD69 is generally associated as the earliest activation cell surface marker on leukocytes, it has been reported that CD25−FoxP3−CD69+ cells from a tumor-bearing mouse can inhibit CD4+ T-cell proliferation in vitro and in vivo [50]. This evidence concerns the gene CD69 and neoplasm.